Skip to main content

Fiscal Wizard · Single-issue tearsheet

TBPH / Jun 20, 2026 Run #7233

TBPH

Theravance Biopharma, Inc.

Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, an once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD); and Ampreloxetine an investigational, once-daily norepinephrine reuptake inhibitor, Which is in Phase 3 clinical trials for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA). It has a strategic collaboration agreement with Viatris Inc. for the development and commercialization of revefenacin, including YUPELRI inhalation solution. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California.

Composite verdict

D 39.6 / 100
Bearish setup · Oscillator 9 drivers · 4 gates blocking
  • Williams %R
  • Commodity Channel Index
  • Engulfing
Consider long put target Δ ~0.70 · ~35 DTE Bearish setup, Grade A → ITM put target

Industry rank 112th of 598 in Biotechnology

rescore-sweep
Technical synthesisRegime: range
Bull 0%Evidence: High · 15 signals100% Bear
Momentum Bearish 26Mean-reversion Bearish 25

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes fromMargin of safety -58%
Asset value $5.76Earnings power value $2.62Price $16.58

Priced above its no-growth earnings power value ($2.62/share) — you're paying for growth and franchise expansion, not just current earnings.

Fundamentals Strong

78.7 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Days Sales Outstanding 100
Margin of Safety 0
EPS Growth (YoY) 100
OCF to Net Income 0
Revenue Growth (YoY) 100
Cash Conversion 0

Technicals Bearish

0.5 / 100

Bearish setup leads (Williams %R, Commodity Channel Index, Engulfing); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
Williams %R 9
Commodity Channel Index 10
Chaikin Money Flow 14

Risk Gates

4 blocking 6 caution

4 guards active, 24 signals gated.

Beneish M-Score Blocking

Bottom-band Beneish M blocks bullish signals — accounting-quality risk.

ADX Trend Weakness Blocking

Weak trend strength blocks trend-following signals in either direction.

Realized Volatility Regime Blocking

High-vol regime mutes mean-reversion signals; low-vol regime mutes breakout signals.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for TBPH.